Back to Journals » OncoTargets and Therapy » Volume 15

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine

Total article views   HTML views PDF downloads Totals
7,904 Dovepress* 6,964+ 407 7,371
PubMed Central* 940 310 1,250
Totals 7,904 717 8,621
*Since 18 February 2022
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 2 4

View citations on PubMed Central and Google Scholar